The protective effects of Levilactobacillus brevis FZU0713 on lipid metabolism and intestinal microbiota in hyperlipidemic rats

Levilactobacillus brevis FZU0713, a potential probiotic previously isolated from the traditional brewing process of Hongqu rice wine, may have the beneficial effects on improving lipid metabolism. This study aimed to evaluate the in vivo protective effects and possible mechanism of L. brevis FZU0713...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaoyun Fan, Qing Zhang, Weiling Guo, Qi Wu, Jinpeng Hu, Wenjian Cheng, Xucong Lü, Pingfan Rao, Li Ni, Youting Chen, Lijiao Chen
Format: Article
Language:English
Published: Tsinghua University Press 2023-09-01
Series:Food Science and Human Wellness
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213453023000216
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832557202972344320
author Xiaoyun Fan
Qing Zhang
Weiling Guo
Qi Wu
Jinpeng Hu
Wenjian Cheng
Xucong Lü
Pingfan Rao
Li Ni
Youting Chen
Lijiao Chen
author_facet Xiaoyun Fan
Qing Zhang
Weiling Guo
Qi Wu
Jinpeng Hu
Wenjian Cheng
Xucong Lü
Pingfan Rao
Li Ni
Youting Chen
Lijiao Chen
author_sort Xiaoyun Fan
collection DOAJ
description Levilactobacillus brevis FZU0713, a potential probiotic previously isolated from the traditional brewing process of Hongqu rice wine, may have the beneficial effects on improving lipid metabolism. This study aimed to evaluate the in vivo protective effects and possible mechanism of L. brevis FZU0713 on the disturbance of lipid metabolism in hyperlipidemic rats fed a high-fat diet (HFD). Results showed that oral administration of L. brevis FZU0713 could significantly inhibit obesity, ameliorate the lipid metabolism disorder, including serum/liver biochemical parameters and hepatic oxidative stress in HFD-fed rats. Histopathological result also indicated that dietary intervention of L. brevis FZU0713 could reduce the accumulation of lipid droplets in liver induced by 8 weeks HFD feeding. Furthermore, L. brevis FZU0713 intervention significantly increased the fecal levels of short-chain fatty acids (SCFAs, including acetate, propionate, butyrate, isobutyrate, valerate and isovalerate) in HFD-fed rats, which may be closely related to the changes of intestinal microbial composition and metabolic function. Intestinal microbiota profiling by 16S rRNA gene sequencing revealed that L. brevis FZU0713 intervention significantly altered the relative abundance of Coprococcus, Butyricicoccus, Intestinimonas, Lachnospiraceae FCS020 group, Ruminococcaceae_NK4A214 group, Ruminococcaceae_UCG-005 and UCG-014 at genus levels. Based on Spearman's rank correlation coefficient, serum and liver lipid metabolism related biochemical parameters were positively correlated with genera Ruminococcus, Pediococcus and Lachnospiraceae, but negatively correlated with genera Pseudoflavonifractor, Butyricicoccus and Intestinimonas. Furthermore, liver metabolomics analysis demonstrated that L. brevis FZU0713 had a significant regulatory effect on the composition of liver metabolites in hyperlipidemic rats, especially the levels of some important biomarkers involved in the metabolic pathways of arachidonic acid metabolism, primary bile acid biosynthesis, amino sugar and nucleotide sugar metabolism, taurine and hypotaurine metabolism, biosynthesis of unsaturated fatty acid, fructose and mannose metabolism, tyrosine metabolism, etc. Additionally, oral administration of L. brevis FZU0713 significantly regulated the mRNA levels of liver genes (including Acat2, Acox1, Hmgcr, Cd36, Srebp-1c and Cyp7a1) involved in lipid metabolism and bile acid homeostasis. In conclusion, our findings provide the evidence that L. brevis FZU0713 has the potential to improve disturbance of lipid metabolism by regulating intestinal microflora and liver metabonomic profile. Therefore, L. brevis FZU0713 may be used as a potential probiotic strain to produce functional food to prevent hyperlipidemia.
format Article
id doaj-art-de4a97b9b2b14f4f813f112d9ab3bfc6
institution Kabale University
issn 2213-4530
language English
publishDate 2023-09-01
publisher Tsinghua University Press
record_format Article
series Food Science and Human Wellness
spelling doaj-art-de4a97b9b2b14f4f813f112d9ab3bfc62025-02-03T05:40:25ZengTsinghua University PressFood Science and Human Wellness2213-45302023-09-0112516461659The protective effects of Levilactobacillus brevis FZU0713 on lipid metabolism and intestinal microbiota in hyperlipidemic ratsXiaoyun Fan0Qing Zhang1Weiling Guo2Qi Wu3Jinpeng Hu4Wenjian Cheng5Xucong Lü6Pingfan Rao7Li Ni8Youting Chen9Lijiao Chen10Institute of Food Science and Technology, College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China; College of Food Science, Fujian Agriculture and Forestry University, Fuzhou 350002, ChinaInstitute of Food Science and Technology, College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China; College of Food Science, Fujian Agriculture and Forestry University, Fuzhou 350002, ChinaInstitute of Food Science and Technology, College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China; College of Food Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China; Jinjiang Food Engineering Research Center, School of Advanced Manufacturing, Fuzhou University, Jinjiang 362200, ChinaInstitute of Food Science and Technology, College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China; Jinjiang Food Engineering Research Center, School of Advanced Manufacturing, Fuzhou University, Jinjiang 362200, ChinaCollege of Food Science, Fujian Agriculture and Forestry University, Fuzhou 350002, ChinaCollege of Food Science, Fujian Agriculture and Forestry University, Fuzhou 350002, ChinaInstitute of Food Science and Technology, College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China; College of Food Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China; Jinjiang Food Engineering Research Center, School of Advanced Manufacturing, Fuzhou University, Jinjiang 362200, China; Corresponding authors.Institute of Food Science and Technology, College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, ChinaInstitute of Food Science and Technology, College of Biological Science and Engineering, Fuzhou University, Fuzhou 350108, China; Department of Hepatopancreatobiliary Surgery, Fujian Research Institute of Abdominal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, ChinaDepartment of Hepatopancreatobiliary Surgery, Fujian Research Institute of Abdominal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, China; Corresponding authors.College of Food Science, Fujian Agriculture and Forestry University, Fuzhou 350002, China; Corresponding authors.Levilactobacillus brevis FZU0713, a potential probiotic previously isolated from the traditional brewing process of Hongqu rice wine, may have the beneficial effects on improving lipid metabolism. This study aimed to evaluate the in vivo protective effects and possible mechanism of L. brevis FZU0713 on the disturbance of lipid metabolism in hyperlipidemic rats fed a high-fat diet (HFD). Results showed that oral administration of L. brevis FZU0713 could significantly inhibit obesity, ameliorate the lipid metabolism disorder, including serum/liver biochemical parameters and hepatic oxidative stress in HFD-fed rats. Histopathological result also indicated that dietary intervention of L. brevis FZU0713 could reduce the accumulation of lipid droplets in liver induced by 8 weeks HFD feeding. Furthermore, L. brevis FZU0713 intervention significantly increased the fecal levels of short-chain fatty acids (SCFAs, including acetate, propionate, butyrate, isobutyrate, valerate and isovalerate) in HFD-fed rats, which may be closely related to the changes of intestinal microbial composition and metabolic function. Intestinal microbiota profiling by 16S rRNA gene sequencing revealed that L. brevis FZU0713 intervention significantly altered the relative abundance of Coprococcus, Butyricicoccus, Intestinimonas, Lachnospiraceae FCS020 group, Ruminococcaceae_NK4A214 group, Ruminococcaceae_UCG-005 and UCG-014 at genus levels. Based on Spearman's rank correlation coefficient, serum and liver lipid metabolism related biochemical parameters were positively correlated with genera Ruminococcus, Pediococcus and Lachnospiraceae, but negatively correlated with genera Pseudoflavonifractor, Butyricicoccus and Intestinimonas. Furthermore, liver metabolomics analysis demonstrated that L. brevis FZU0713 had a significant regulatory effect on the composition of liver metabolites in hyperlipidemic rats, especially the levels of some important biomarkers involved in the metabolic pathways of arachidonic acid metabolism, primary bile acid biosynthesis, amino sugar and nucleotide sugar metabolism, taurine and hypotaurine metabolism, biosynthesis of unsaturated fatty acid, fructose and mannose metabolism, tyrosine metabolism, etc. Additionally, oral administration of L. brevis FZU0713 significantly regulated the mRNA levels of liver genes (including Acat2, Acox1, Hmgcr, Cd36, Srebp-1c and Cyp7a1) involved in lipid metabolism and bile acid homeostasis. In conclusion, our findings provide the evidence that L. brevis FZU0713 has the potential to improve disturbance of lipid metabolism by regulating intestinal microflora and liver metabonomic profile. Therefore, L. brevis FZU0713 may be used as a potential probiotic strain to produce functional food to prevent hyperlipidemia.http://www.sciencedirect.com/science/article/pii/S2213453023000216Levilactobacillus brevis FZU0713Lipid metabolismHyperlipidemiaIntestinal microbiotaLiver metabolomicsmRNA expression
spellingShingle Xiaoyun Fan
Qing Zhang
Weiling Guo
Qi Wu
Jinpeng Hu
Wenjian Cheng
Xucong Lü
Pingfan Rao
Li Ni
Youting Chen
Lijiao Chen
The protective effects of Levilactobacillus brevis FZU0713 on lipid metabolism and intestinal microbiota in hyperlipidemic rats
Food Science and Human Wellness
Levilactobacillus brevis FZU0713
Lipid metabolism
Hyperlipidemia
Intestinal microbiota
Liver metabolomics
mRNA expression
title The protective effects of Levilactobacillus brevis FZU0713 on lipid metabolism and intestinal microbiota in hyperlipidemic rats
title_full The protective effects of Levilactobacillus brevis FZU0713 on lipid metabolism and intestinal microbiota in hyperlipidemic rats
title_fullStr The protective effects of Levilactobacillus brevis FZU0713 on lipid metabolism and intestinal microbiota in hyperlipidemic rats
title_full_unstemmed The protective effects of Levilactobacillus brevis FZU0713 on lipid metabolism and intestinal microbiota in hyperlipidemic rats
title_short The protective effects of Levilactobacillus brevis FZU0713 on lipid metabolism and intestinal microbiota in hyperlipidemic rats
title_sort protective effects of levilactobacillus brevis fzu0713 on lipid metabolism and intestinal microbiota in hyperlipidemic rats
topic Levilactobacillus brevis FZU0713
Lipid metabolism
Hyperlipidemia
Intestinal microbiota
Liver metabolomics
mRNA expression
url http://www.sciencedirect.com/science/article/pii/S2213453023000216
work_keys_str_mv AT xiaoyunfan theprotectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT qingzhang theprotectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT weilingguo theprotectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT qiwu theprotectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT jinpenghu theprotectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT wenjiancheng theprotectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT xuconglu theprotectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT pingfanrao theprotectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT lini theprotectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT youtingchen theprotectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT lijiaochen theprotectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT xiaoyunfan protectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT qingzhang protectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT weilingguo protectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT qiwu protectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT jinpenghu protectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT wenjiancheng protectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT xuconglu protectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT pingfanrao protectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT lini protectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT youtingchen protectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats
AT lijiaochen protectiveeffectsoflevilactobacillusbrevisfzu0713onlipidmetabolismandintestinalmicrobiotainhyperlipidemicrats